HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masahiro Nomoto Selected Research

Dopamine (Intropin)

1/2019Behavioral tests predicting striatal dopamine level in a rat hemi-Parkinson's disease model.
5/2017Clinical manifestations of nonmotor symptoms in 1021 Japanese Parkinson's disease patients from 35 medical centers.
7/2012Coadministration of domperidone increases plasma levodopa concentration in patients with Parkinson disease.
9/2011A cytokine mixture of GM-CSF and IL-3 that induces a neuroprotective phenotype of microglia leading to amelioration of (6-OHDA)-induced Parkinsonism of rats.
9/2004[The pharmacological and rational theory for the drug development of Parkinson's disease].
7/2004Antinociceptive mechanism of L-DOPA.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masahiro Nomoto Research Topics

Disease

44Parkinson Disease (Parkinson's Disease)
03/2022 - 12/2003
8Dyskinesias (Dyskinesia)
05/2022 - 07/2007
6Pain (Aches)
10/2021 - 07/2004
3Movement Disorders (Movement Disorder)
05/2022 - 09/2004
3Sleepiness
07/2018 - 01/2014
3Parkinsonian Disorders (Parkinsonism)
09/2011 - 09/2004
2Hypokinesia (Bradykinesia)
03/2022 - 10/2021
2Tremor (Tremors)
03/2022 - 02/2018
2Dementia (Dementias)
01/2021 - 07/2019
2Myoclonic Epilepsies (Myoclonic Encephalopathy)
01/2019 - 12/2018
2Neoplasms (Cancer)
02/2016 - 02/2009
1Schizophrenia (Dementia Praecox)
05/2022
1Tardive Dyskinesia
05/2022
1Dystonia (Limb Dystonia)
10/2021
1Alzheimer Disease (Alzheimer's Disease)
01/2021
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021
1Major Depressive Disorder (Major Depressive Disorders)
01/2021
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
12/2020
1Stomach Ulcer (Gastric Ulcer)
07/2019
1Sleep Initiation and Maintenance Disorders (Insomnia)
07/2019
1Drug-Related Side Effects and Adverse Reactions
07/2019
1Multiple Sclerosis
06/2019
1Encephalitis (Encephalitis, Rasmussen)
06/2019
1Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy)
03/2019
1MERRF Syndrome (Myoclonic Epilepsy and Ragged Red Fibers)
12/2018
1Disorders of Excessive Somnolence (Hypersomnia)
04/2018
1Onychomycosis (Tinea Unguium)
01/2018
1Crystalluria
12/2017
1Gout
12/2017
1Cardiovascular Diseases (Cardiovascular Disease)
12/2017
1Urolithiasis
12/2017
1Fatigue
05/2017
1Thrombophilia
09/2015
1Stroke (Strokes)
09/2015
1Partial Epilepsies (Epilepsy, Partial)
01/2014
1Tropical Spastic Paraparesis (Tropical Spastic Paraplegia)
01/2013
1Nervous System Diseases (Neurological Disorders)
01/2013

Drug/Important Bio-Agent (IBA)

26Levodopa (L Dopa)FDA LinkGeneric
10/2021 - 12/2003
6Dopamine (Intropin)FDA LinkGeneric
01/2019 - 07/2004
5safinamideIBA
03/2022 - 01/2020
5rotigotineFDA Link
02/2018 - 09/2013
5Pharmaceutical PreparationsIBA
12/2017 - 09/2004
3opicaponeIBA
01/2021 - 01/2021
3ropinirole (Requip)FDA LinkGeneric
01/2021 - 12/2014
3Proteins (Proteins, Gene)FDA Link
12/2020 - 03/2005
3Monoamine Oxidase (MAO)IBA
01/2020 - 11/2005
3Selegiline (E250)FDA LinkGeneric
07/2019 - 01/2010
3Mitochondrial DNA (mtDNA)IBA
03/2019 - 12/2018
31- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
04/2018 - 08/2007
3Amantadine (Aman)FDA LinkGeneric
12/2010 - 11/2005
2Cholinergic Antagonists (Anticholinergics)IBA
05/2022 - 11/2005
2TabletsIBA
01/2021 - 01/2020
2Dopamine Agonists (Dopamine Agonist)IBA
01/2021 - 11/2005
2Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2013
2Messenger RNA (mRNA)IBA
01/2021 - 12/2020
2Zonisamide (Zonegran)FDA LinkGeneric
07/2019 - 04/2011
2ApomorphineFDA Link
11/2015 - 08/2014
2Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
01/2014 - 07/2007
2CannabinoidsIBA
07/2007 - 09/2004
2Opioid Analgesics (Opioids)IBA
07/2007 - 09/2004
1Botulinum Toxins (Botulinum Toxin)IBA
05/2022
1Antipsychotic Agents (Antipsychotics)IBA
05/2022
1Tetrabenazine (Nitoman)FDA Link
05/2022
1Dopamine AntagonistsIBA
05/2022
1Reserpine (Serpasil)FDA Link
05/2022
1istradefyllineIBA
10/2021
1Vesicular Transport Adaptor ProteinsIBA
01/2021
1Phosphatidylinositols (Phosphatidylinositol)IBA
01/2021
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
12/2020
1Guanfacine (Tenex)FDA LinkGeneric
12/2020
1Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
12/2020
1Duloxetine Hydrochloride (Cymbalta)FDA Link
07/2020
1Sodium Channels (Sodium Channel)IBA
01/2020
1Sodium Channel BlockersIBA
01/2020
1AntibodiesIBA
06/2019
1Indicators and Reagents (Reagents)IBA
01/2019
1ProdrugsIBA
12/2018
1Carbidopa (Lodosyn)FDA LinkGeneric
12/2018
1Dopamine Agents (Dopaminergic Agents)IBA
04/2018
1Modafinil (Provigil)FDA Link
04/2018
1Ciclopirox (Loprox)FDA LinkGeneric
01/2018
1amorolfineIBA
01/2018
12- (3,5- dimethyl- 1H- pyrazol- 1- yl)- 5- methylphenolIBA
01/2018
1efinaconazoleIBA
01/2018
1Antifungal AgentsIBA
01/2018
1tavaboroleIBA
01/2018
1InosineFDA Link
12/2017
1Uric Acid (Urate)IBA
12/2017
1Trastuzumab (Herceptin)FDA Link
02/2016
1CholesterolIBA
09/2015
1fibrin fragment D (D-dimer)IBA
09/2015
1AlbuminsIBA
09/2015
1Fibrinogen (Factor I)FDA Link
09/2015
1Pregabalin (Lyrica)FDA Link
01/2014
1NicotineFDA Link
03/2013

Therapy/Procedure

12Therapeutics
05/2022 - 03/2007
2Drug Therapy (Chemotherapy)
01/2017 - 08/2007
1Deep Brain Stimulation
05/2022
1Digestive System Surgical Procedures
01/2020
1Tobacco Use Cessation Devices
03/2013